| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Zhong,Zheng-You | Chairman | 11.72% | HAO QUN DEVELOPMENT CO., LTD. |
| Lin,Yu-Long | Director | 15.12% | Evermega Energy and Resources Technology Co., Ltd |
| Zhang,Zheng-Guang | Director | 6.01% | ZHENG SHENG INVESTMENT CO., LTD. |
| Chen,Kuan-Rong | Director | 0.70% | |
| Zhang,Xuan-Han | Director | 0.11% | |
| Sun,Zheng-Qiang | Independent Director | 0.00% | |
| Cai,Xian-Tang | Independent Director | 0.00% | |
| Chen,Zong-De | Independent Director | 0.00% | |
| Chen,Mei-Qin | Independent Director | 0.00% |
Change Company Name to Revivegen Co., Ltd.
2024/07/03
Change Company Name to LIBAIJING CO., LTD. (FORMER NAME: LIBAIJING ENVIRONMENTAL PROTECTION TECHNOLOGY CO., LTD.)
2023/06/29
Change Capital to 1,000,000,000
2021/11/02
Change Capital to 360,000,000
2019/01/29
Change Capital to 120,000,000
2017/08/07
Change Capital to 100,000,000
2017/06/22
Change Person in Charge to Zhong,Zheng-You
2017/06/22
Change Capital to 80,000,000
2017/05/31
Change Capital to 70,000,000
2017/04/12
Change Person in Charge to Zhong,Zheng-You
2017/02/20
Change Capital to 50,000,000
2016/10/28
下載完整報告查看完整數據
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 227,536 | 393,585 | 339,164 |
| Operating cost | 165,089 | 282,936 | 223,138 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 62,447 | 110,649 | 116,026 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 62,447 | 110,649 | 116,026 |
| Operating expenses | 42,497 | 80,118 | 70,086 |
| Other gain (loss), net | -3,546 | -497 | -2,769 |
| Operating profit (loss) | 16,404 | 30,034 | 43,171 |
| Non-operating income and expenses | 24,259 | 17,275 | -4,930 |
| Net profit (loss) before tax | 40,663 | 47,309 | 38,241 |
| Income tax expense (benefits) | 6,096 | 11,318 | 12,472 |
| Net profit (loss) of ongoing business for the current period | 34,567 | 35,991 | 25,769 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 34,567 | 35,991 | 25,769 |
| Other comprehensive profit (loss), net | 3,555 | 2,098 | 766 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 38,122 | 38,089 | 26,535 |
| Net profit (loss) attributable to owners of parent company | 29,519 | 40,811 | 35,145 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | 5,048 | -4,820 | -9,376 |
| Comprehensive profit (loss) attributable to owners of parent company | 33,074 | 42,909 | 35,911 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | 5,048 | -4,820 | -9,376 |
| Basic earnings per share (yuan) | 0 | 1 | 1 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 66,155 | 108,387 | 86,424 |
| Net cash inflows (outflows) from investing activities | -627,195 | -1,809,601 | -760,273 |
| Net cash inflow (outflow) from financing activities | 488,630 | 1,944,463 | 538,727 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | -72,410 | 243,249 | -135,122 |
| Beginning balance of cash and cash equivalents | 454,999 | 211,750 | 346,872 |
| Ending balance of cash and cash equivalents | 382,589 | 454,999 | 211,750 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 462,314 | 533,963 | 357,496 |
| Non-current asset | 4,169,378 | 3,467,743 | 1,718,098 |
| Total asset | 4,631,692 | 4,001,706 | 2,075,594 |
| Current liability | 364,105 | 276,416 | 325,211 |
| Non-current liability | 1,795,300 | 1,681,985 | 521,769 |
| Total liability | 2,159,405 | 1,958,401 | 846,980 |
| share capital | 600,010 | 475,413 | 340,730 |
| Equity - secruity token | - | - | - |
| capital reserve | 833,551 | 734,866 | 438,702 |
| retained earning | 64,529 | 63,432 | 57,337 |
| Other equity | 6,419 | 2,864 | 766 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 1,504,509 | 1,276,575 | 837,535 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 967,778 | 766,730 | 391,079 |
| Total Equity | 2,472,287 | 2,043,305 | 1,228,614 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 28 | 26 | 24 |
